JP2024509625A5 - - Google Patents

Info

Publication number
JP2024509625A5
JP2024509625A5 JP2023556473A JP2023556473A JP2024509625A5 JP 2024509625 A5 JP2024509625 A5 JP 2024509625A5 JP 2023556473 A JP2023556473 A JP 2023556473A JP 2023556473 A JP2023556473 A JP 2023556473A JP 2024509625 A5 JP2024509625 A5 JP 2024509625A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
membered
hydrogen
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023556473A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024509625A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/000134 external-priority patent/WO2022195355A1/en
Publication of JP2024509625A publication Critical patent/JP2024509625A/ja
Publication of JP2024509625A5 publication Critical patent/JP2024509625A5/ja
Pending legal-status Critical Current

Links

JP2023556473A 2021-03-15 2022-03-14 ベンゾイソオキサゾール誘導体及びその使用 Pending JP2024509625A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163161141P 2021-03-15 2021-03-15
US63/161,141 2021-03-15
US202163164125P 2021-03-22 2021-03-22
US63/164,125 2021-03-22
PCT/IB2022/000134 WO2022195355A1 (en) 2021-03-15 2022-03-14 Benzisoxazole derivatives and uses thereof

Publications (2)

Publication Number Publication Date
JP2024509625A JP2024509625A (ja) 2024-03-04
JP2024509625A5 true JP2024509625A5 (https=) 2025-03-24

Family

ID=81579856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023556473A Pending JP2024509625A (ja) 2021-03-15 2022-03-14 ベンゾイソオキサゾール誘導体及びその使用

Country Status (4)

Country Link
US (1) US20250276964A1 (https=)
EP (1) EP4308559A1 (https=)
JP (1) JP2024509625A (https=)
WO (1) WO2022195355A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4612128A4 (en) 2022-11-04 2025-09-10 Bristol Myers Squibb Co COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HEMOGLOBINOPATHIES
WO2024255810A1 (en) * 2023-06-15 2024-12-19 Hangzhou Glubio Pharmaceutical Co., Ltd Dihydropyrimidine-2, 4 (1h, 3h) -dione-containing polycyclic derivatives and pharmaceutical composition thereof, preparation method thereof and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007524596A (ja) 2003-02-28 2007-08-30 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 共結晶医薬組成物
EA026353B1 (ru) 2012-01-17 2017-03-31 Астеллас Фарма Инк. Соединение пиразинкарбоксамида
IL312367A (en) * 2017-01-31 2024-06-01 Arvinas Operations Inc Cereblon ligands and bifunctional compounds comprising the same
LT3710439T (lt) 2017-11-15 2023-05-10 Mirati Therapeutics, Inc. Kras g12c inhibitoriai
CN120698983A (zh) * 2018-12-20 2025-09-26 C4医药公司 靶向蛋白降解
JP7209897B2 (ja) * 2019-09-12 2023-01-20 メッドシャイン ディスカバリー インコーポレイテッド Ｃｒｂｎタンパク質モジュレーターとしての二環式化合物
PY2217419A (es) * 2021-03-15 2022-09-27 Novartis Ag Derivados de pirazolopiridina y sus usos

Similar Documents

Publication Publication Date Title
JP2024509981A5 (https=)
JP2024520654A5 (https=)
EP3743065A1 (en) Sulfonamide derivatives for protein degradation
JP2008510018A5 (https=)
KR20150082633A (ko) 경구적으로 생체이용가능한 신규 호흡 조절 제어 화합물 및 그의 사용 방법
KR102304111B1 (ko) 베타-클로로시클로펜탄의 친수성 에스테르 전구약물의 이용에 의한 감소된 중심 각막 비후
US11434205B2 (en) Substituted imidazole carboxylate derivatives and the use thereof
JP2024509625A5 (https=)
IL308094A (en) 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR MEDICAL USES
US20250361218A1 (en) Agents and methods for treating dysproliferative diseases
WO2016130460A9 (en) Phthalazinone pyrazole derivatives for treating retinal degenerative disease
US12473305B2 (en) Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof
JP2025509886A (ja) サイクリン依存性キナーゼ２阻害剤としてのスルホンアミド誘導体
JP2019504016A (ja) アルキルジヒドロキノリンスルホンアミド化合物
AU2014335859B2 (en) Chromene derivatives substituted by alkoxide as inhibitors of the TCR-Nck interaction
WO2018200571A1 (en) Substituted 2,3-dihydro-1h-indene analogs and methods using same
JP7661969B2 (ja) １，４，５，６－テトラヒドロピリミジン－２－アミン誘導体
JP2022541311A5 (https=)
AU2023208523A1 (en) Esters of 8-methyl-8-azabicyclo[3.2.1] octan-3-yl 3-hydroxy-2-phenylpropanoate
CN117586204A (zh) 异硒唑酮类化合物、其合成方法及用途
WO2015175075A1 (en) Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
EP4470608A1 (en) Lysophosphatidylserine analogue, and lysophosphatidylserine analogue-containing phamaceutical composition for treating or preventing fibrosis
JP2025529076A (ja) ＡｈＲ媒介疾患の治療に使用するタピナロおよびそのアナログ製剤
CN114341137B (zh) 二氢嘧啶衍生物及其用途
RU2023135650A (ru) Производные 3-(1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и способы их применения